Role of glucagon-like peptide-1 in vascular endothelial dysfunction

Indian Journal of Experimental Biology

Volumn 48, Issue 1, 2010, Pages 61-69

  Goyal, Sandeep ^a   Kumar, Suresh ^a   Bijjem, Krishnareddy V ^b   Singh, Manjeet ^b  

^a SD College of Pharmacy   (India)

^b ISF COLLEGE OF PHARMACY   (India)

Author keywords

Diabetes mellitus; Exendin 4; Hyperhomocysteinemia; Vascular endothelial dysfunction

Indexed keywords

RATTUS;

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; HEPTANOIC ACID DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NOS3 PROTEIN, RAT; PEPTIDE; PYRROLE DERIVATIVE; VENOM;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HYPERHOMOCYSTEINEMIA; IN VITRO STUDY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HEPTANOIC ACIDS; HYPERHOMOCYSTEINEMIA; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDES; PYRROLES; RATS; RATS, WISTAR; VENOMS;

EID: 77951927894     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Li H & Forstermann U, Nitric oxide in the pathogenesis of vascular disease, J Pathol, 190 (2000) 244.
2. De Vriese A S, Verbeuren T J, van de Voorde J, Lameire N H & Vanhoutte P M, Endothelial dysfunction in diabetes, Br J Pharmacol, 130 (2000) 963.
3. Lentz S R, Rodionov R N & Dayal S, Hyperhomocysteinemia, endothelial dysfunction and cardiovascular risk: the potential role of ADMA, Atheroscler Suppl, 4 (2003) 61.
4. Luscher T F, Raij L & Vanhoutte P M, Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats, Hypertension, 9 (1987) 157.
5. Bonetti P O, Lerman L & Lerman A, Endothelial dysfunction: A marker of atherosclerotic risk, Arterioscler Thromb Vasc Biol, 23 (2003) 168.
6. Vane JR, Anggard E E & Botting R M, Regulatory functions of the vascular endothelium, N Eng J Med, 323 (1990) 27.
7. Masaki T, Possible role of endothelin in endothelial regulation of vascular tone, Annnual Rev Pharmacol Toxicol, 35 (1995) 235.
8. Danon D & Skutelsky E, Endothelial surface charge and its possible relationship to thrombogenesis, Ann. N Y Acad Sci, 275 (1976) 47.
9. Delafontaine P, Insulin-like growth factor I and its binding proteins in the cardiovascular system, Cardiovasc Res, 30 (1995) 825.
10. Pieper G M, Langenstroer P & Siebeneich W, Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals, Cardiovasc Res, 34 (1997) 145.
11. Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollar L & Koller A, Simultaneously increased TXA(2) activity in isolated arterioles and platelets of rats with hyperhomocysteinemia, Arterioscler Thromb Vase Biol, 20 (2000) 1203.
12. Ungwari Z, Paeher P, Rischak K, Szollar L & Koller A, Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet induced hyperhomocystenemia, Arterioscler Thromb Vase Biol, 19 (1999) 1899.
13. Endemann D H & Schiffrin E L, Endothelial dysfunction, J Am Soc Nephrol, 15 (2004) 1983.
14. Gutniak M, Orskov C, Holst J J, Ahren B & Efendic S, Antidiabetogenic effects of glucagon-like-peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus, N Eng J Med, 326 (1992) 1316.
15. D'Alessio D A, Prigeon R L & Ensinck J W, Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like-peptide I, Diabetes, 44 (1995) 1433.
16. Xu G, Kaneto H, Laybutt D R, Duvivier-Kali V F, Trivedi N, Suzuma K, King G L, Weir G C & Bonner-Weir S, Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes, Diabetes, 56 (2007) 1551.
17. Patterson Steven, Flatt Peter R & McClenaghan Neville H, Homocysteine and other structurally-diverse amino thiols can alter pancreatic beta cell function without evoking cellular damage, Diab/Metab Res Rev, 23 (2007) 324.
18. Eng J, Kleinman W A, Singh L & Raufman J P, Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom: further evidence for an exendin receptor on dispersed acini from guinea pig pancreas, J Biol Chem, 267 (1992) 7402.
19. Perry T & Greig N H, The glucagons-like peptides: a double-edged therapeutic sword? Trends Pharmacol Sci, 24 (2003) 377.
20. Ding Xiaokun, Saxena Neeraj K, Lin Songbai, Gupta Narita & Anania Frank A, Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice, Liver Biol Pathobiol, 43 (2006) 173.
21. Mentlein R, Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides, Regul Pept, 85 (1999) 9.
22. Acitores A, Gonzalez N, Sancho V, Valverde I & Villanueva-Penacarrillo M L, Cell signaling of glucagon-like peptide-1 in rat skeletal muscle, J Endocrin, 180 (2004) 389.
23. Brubaker P L & Druker D J, Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system, Endocrinology, 145 (2004) 2653.
24. Widenmaier Scott B, Sampaio Arthur V, Underhill T Michael & McIntosh Christopher H S, Noncanonical Activation of Akt/Protein Kinase B in (5-Cells by the Incretin Hormone Glucose-dependent Insulinotropic Polypeptide, J Biol Chem, 284 (2009) 10764.
25. Misruski D, Tatchum-Talom R, McNeill J R & Gopalkrishnan V, Vanadate evoked relaxation of the perfused rat mesenteric vascular bed, Life Sci, 67 (2000) 1369.
26. + -independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress, Circ Res, 82 (1998) 686.
27. Dimmeler S, Fleming B, Fisslthaler B, Herman C, Busse B & Zeiher A M, Activation of nitric oxide synthase in endothelial cells by Akt dependent phosphorylation, Nature, 399 (1999) 601.
28. XIE Yun, WANG Shao-xin, SHA Wei-wei, ZHOU Xue, WANG Wei-lin, HAN Li-pin, LI Dai-qing & YU De-min, Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation, Chin Med J, 121 (2008) 2134.
29. Liu J, Yin F, Zheng X, Jing J & Hu Y, Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway, Neurochem Int, 51 (2007) 361.
30. Shah Dhvanit & Singh Manjeet, Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats, Mol Cell Biochem, 295 (2007) 65.
31. Dimitrova K R, Degroot K W, Pacquing A M, Suyderhoud J P, Pirovic E A, Munro T J, Wieneke J A, Myers A K & Kim Y D, Estradiol prevents homocysteine-induced endothelial injury in male rats, Cardiovasc Res, 53 (2002) 589.
32. Mittra S & Singh M, Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta, Mol Cell Biochem, 183 (1998) 63.
33. Ignarro L J, Byrns R E, Buga G M, Wood K S & Chaudhuri G, Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation, J Pharmacol Ex Ther, 244 (1998) 181.
34. Sastry KV, Moudgal R P, Mohan J, Tyagi J S & Rao G S, Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy, Anal Biochem, 306 (2002) 79.
35. Kohn A D, Summer S A, Birnbaum M J & Roth R A, Expression of constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation, J Biol Chem, 271 (1996) 313-72.
36. Calera M R, Martinez C, Liu H, Jack AKE, Birnbaum M J & Pilch P F, Insulin increases the association of Akt-2 with Glut4-containing vesicles, J Biol Chem, 273 (1998) 7201.
37. Begum N, Sandu O A, Ito M, Lohman S M & Smolenski A, Active Rho kinase associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells, J Biol Chem, 22 (2001) 6214.
38. Waly M, Olteanu H, Banerjee R, Choi S-W, Mason J B, Parker B S, Sukumar S, Shim S, Sharma A, Benzecry J M, Power-Charnitsky V-A & Deth R C, Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopemental toxins and thimerosal, Mol Psychiatry, 9 (2004) 358.
39. Fonesca V, Keebler M, Dicker-Brown A, DeSouza C, Poirier L A, Murthy S N & McNamara D B, The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in zucker rats, Metabolism, 61 (2002) 783.
40. Zdychova J & Komers R, Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications, Physiol Res, 54 (2005) 1.
41. Zhang H S, Cao E H & Qin J F, Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway, Pharmacology, 74 (2005) 57.
42. Stitt T N, Drujan D, Clarke B A, Panaro F, Timofeyva Y, Kline W O, Gonzalez M, Yancopoulos G D & Glass D J, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors, Mol Cell, 14 (2004) 395.
43. Potente M, Urbich C, Sasaki K I, Hofmann W K, Heeschen C, Aicher A, Kollipara R, DePinho R A, Zeiher A M & Dimmeler S, Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization, J Clin Invest, 115 (2005) 2382.
44. Fulton D, Gratton J P, McCabe T J, Fontana J, Fujio Y, Walsh K, Franke T F, apapetropolous A & Sessa W C, Regulation of endothelium derived nitric oxide production by the protein kinase Akt, Nature, 400 (1999) 792.
45. Kung C F, Moreau P, Takase H & Luscher T F, L-NAME hypertension alters endothelial and smooth muscle function in rat aorta, Hypertension, 26 (1994) 744.
46. Sibel O, Nilufer K, Selim A, Sule B O & Ahmet G A, Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats, Pharmacology, 74 (2005) 119.
47. Ananda B, Nisha C, William Schrage, Robert A R, Rita B & Michael J J, Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepride, Am J Physiol Endocrinol Metab, 293 (2007) E1289.
48. Hayden M R & Tyagi S C, Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleotropic effects of folate supplementation, Nutr J, 3 (2004) 4.